Related News
Domestic IPO resumes after nine-month freeze
By Leo Zhang |
20:26 UTC+8 June 18, 2009
|
Online Edition
Online Edition
GUILIN Sanjin Pharmaceutical Co will launch the first initial public offering on Chinese mainland in nine months as the regulator has eventually lifted the ban after the sagging stock market recovered.
The traditional Chinese medicine maker today received the approval from the China Securities Regulatory Commission for the new stock sale in Shenzhen, investment banking sources told Shanghai Daily.
Sanjin is expected to start a preliminary price consultation with investors next week and may finally list its shares late this month or early next month, said the sources familiar with the matter.
"Sanjin is a small-size firm and its listing won't likely cause big pressure on liquidity or cause the index to plunge," said Xu Wenyu, a China Galaxy Securities Co trader. "The company can fetch a good valuation as people will definitely chase the first IPO after waiting for such a long time."
The CSRC halted domestic IPOs in September after the Shanghai Composite Index slumped nearly 60 percent in the first nine months of last year on worries more equity supplies may lead the market to collapse.
The benchmark stock barometer has gained more than a third since the suspension started partly thanks to the government's fiscal stimulus package, which is on track to help the country's economy step onto a recovery path.
The traditional Chinese medicine maker today received the approval from the China Securities Regulatory Commission for the new stock sale in Shenzhen, investment banking sources told Shanghai Daily.
Sanjin is expected to start a preliminary price consultation with investors next week and may finally list its shares late this month or early next month, said the sources familiar with the matter.
"Sanjin is a small-size firm and its listing won't likely cause big pressure on liquidity or cause the index to plunge," said Xu Wenyu, a China Galaxy Securities Co trader. "The company can fetch a good valuation as people will definitely chase the first IPO after waiting for such a long time."
The CSRC halted domestic IPOs in September after the Shanghai Composite Index slumped nearly 60 percent in the first nine months of last year on worries more equity supplies may lead the market to collapse.
The benchmark stock barometer has gained more than a third since the suspension started partly thanks to the government's fiscal stimulus package, which is on track to help the country's economy step onto a recovery path.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
